In the carton
- ✓ One pre-filled 3 ml multi-dose research pen: CJC-1295 & Ipamorelin 20 mg blend (20 mg · 3 ml)
- ✓ 8 pen needles
- ✓ Printed instruction leaflet
- ✓ Verification sticker
- ✓ Batch label with a QR link to the Certificate of Analysis
- ✓ Insulated cold-chain packaging with a cooling element and temperature indicator
CJC-1295 & Ipamorelin 20 mg · 3 ml
CJC-1295 (no DAC) and Ipamorelin 20 mg combined blend supplied as a pre-filled multi-dose research pen (3 ml solution). A GHRH analogue paired with a selective ghrelin-receptor agonist, used in laboratory studies of pulsatile growth-hormone secretion. Batch HPLC-tested, Certificate of Analysis published. Supplied strictly for laboratory research use. Not for human or veterinary use.
Checkout requires an account and the research-use declaration.
Research use only. For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application. This product is not a medicine, food supplement or cosmetic, and no medical, therapeutic or performance claims are made or implied. Read our research use only policy
Specification
| Compound | CJC-1295 & Ipamorelin |
|---|---|
| CAS number | 863288-34-0 (CJC-1295) · 170851-70-4 (Ipamorelin) |
| Declared quantity | 20 mg |
| Format | Solution in a sealed, pre-filled multi-dose research pen (20 mg · 3 ml) |
| Purity (HPLC) | 99.09% |
| Batch | CJIP9837 |
| Storage | 2–8 °C, protected from light, do not freeze |
| Intended use | Laboratory research use only. Not for human or veterinary use. |
One sealed, pre-filled 3 ml multi-dose research pen with a batch label and a QR link to the Certificate of Analysis, shipped in insulated cold-chain packaging with a cooling element and a temperature indicator. The carton also contains 8 pen needles, a printed instruction leaflet and a verification sticker.
An independent laboratory tests every batch by HPLC for identity and purity. The Certificate of Analysis for this product is published below and on our certificates page; the batch number on the certificate matches the batch printed on the label.
Store refrigerated at 2–8 °C. Protect from light. Do not freeze. Keep out of the reach of children and animals. Dispose of in accordance with local regulations.
Orders placed before 12:00 (CET) on a business day are dispatched the same day in cold-chain packaging, tracked with DPD, and arrive in 3–5 business days. Unopened products can be returned within 30 days of delivery; damaged products are replaced free of charge.
CJC-1295 & Ipamorelin
What CJC-1295 & Ipamorelin is
CJC-1295 without DAC (modified GRF 1-29, CAS 863288-34-0) is a synthetic analogue of growth-hormone-releasing hormone. Ipamorelin (CAS 170851-70-4) is a synthetic pentapeptide agonist at the ghrelin receptor (GHS-R1a).
This material is a combined blend of both peptides, 20 mg in total, supplied in solution in a sealed 3 ml multi-dose research pen. Identity and purity of each batch are confirmed by HPLC and documented on the published Certificate of Analysis.
In the research literature
In the published literature the two compounds are used together to study the somatotropic axis: how GHRH-receptor and ghrelin-receptor signalling interact to shape pulsatile growth-hormone release in pituitary cell and animal models.
Neither CJC-1295 nor Ipamorelin is an authorised medicinal product in the European Union or elsewhere. This material is not a medicine, and nothing on this page describes or implies any effect in humans or animals.
This page identifies a research material. It contains no instructions for use, and no dosing or administration information is provided. For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application.
